STOCK TITAN

The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

CERRITOS, Calif., Sept. 15, 2022 - The Oncology Institute, Inc. (NASDAQ: TOI) announced that its CEO, Brad Hively, will join the panel on 'Next Frontier - Value Based Care for Sub-Capitation/Specialties' at the Nephron 2nd Annual Physician Enablement Symposium on September 22 at 9:00 am EST. Founded in 2007, TOI is one of the largest value-based oncology groups in the U.S., serving around 1.7 million patients through over 50 clinic locations, employing more than 90 clinicians.

Positive
  • None.
Negative
  • None.

CERRITOS, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate on the “Next Frontier - Value Based Care for Sub-Capitation/Specialties” panel at the Nephron 2nd Annual Physician Enablement Symposium on Thursday, September 22 at 9:00am EST.

About The Oncology Institute, Inc.

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.7 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 90+ employed clinicians and more than 700 teammates in over 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Contacts

Media

The Oncology Institute
Julie Korinke
juliekorinke@theoncologyinstitute.com
(562) 735-3226 x 88806

Revive
Michael Petrone
mpetrone@reviveagency.com
(615) 760-4542

Investors

Solebury Trout
Maria Lycouris
investors@theoncologyinstitute.com


FAQ

What event is Brad Hively participating in for The Oncology Institute?

Brad Hively, CEO of The Oncology Institute, will be on the 'Next Frontier - Value Based Care for Sub-Capitation/Specialties' panel at the Nephron 2nd Annual Physician Enablement Symposium on September 22, 2022.

What is the date and time of the Nephron Symposium where TOI's CEO will speak?

The Nephron Symposium will occur on September 22, 2022, at 9:00 am EST.

What services does The Oncology Institute provide?

The Oncology Institute offers specialized, value-based cancer care, including clinical trials and transfusions, serving approximately 1.7 million patients.

Where is The Oncology Institute located?

The Oncology Institute is headquartered in Cerritos, California, with over 50 clinic locations across the United States.

What is the stock symbol for The Oncology Institute?

The Oncology Institute is traded under the stock symbols TOI and TOIIW on NASDAQ.

The Oncology Institute, Inc.

NASDAQ:TOI

TOI Rankings

TOI Latest News

TOI Stock Data

21.14M
75.49M
19.56%
45.35%
0.33%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
CERRITOS